Bryan Johnson, a 48-year-old biotech entrepreneur determined to live "multiple lifetimes" with his teenage son, shared the ...

Incyte (Nasdaq:INCY) announced today that it has scheduled its second quarter financial results conference call and webcast for 8:00 a.m. ET on Tuesday, July 28, 2026.

Elevated interferon levels are independently linked to key metabolic abnormalities in SLE, including dyslipidemia and pancreatic β‑cell dysfunction.

Before starting cell therapy, patients need more than hope — they need a plan. Dr. Muhammad Tariq breaks down what to expect ...

That ordinary persistence would eventually give birth to a revolution. In laboratories across the country today, that same ...

Longevity medicine relies on advanced biomarker analysis to support preventive healthcare and more personalized patient ...

Incyte ( (INCY)) has provided an update. On July 6, 2026, Incyte completed its $1.25 billion acquisition of Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics, in a deal that also ...

New research led by Mass General Brigham investigators suggests that the Bacillus Calmette-Guérin (BCG) vaccine - which is ...

Bryan Johnson has spent millions of dollars attempting to "eliminate death" and has documented his biohacking journey on ...

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

Incyte completes acquisition of Vega Therapeutics, a wholly owned subsidiary of Star Therapeutics: Wilmington, Delaware Wednesday, July 8, 2026, 13:00 Hrs [IST] Incyte, a biopharm ...

Summary: A new study demonstrates that the BCG vaccine actively remodels the immune environment surrounding the human brain and spinal cord. By tracking older adults over 12 months, the research team ...